Ballard Mann
Physician Assistant · Baker, LANPI 1942580048
Payments from drug & device makers
Across 178 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$380
- Bayer$364
- Novo Nordisk$354
- Abbott$341
- Takeda Pharmaceuticals U.S.A., Inc.$260
- AbbVie$192
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,095100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 27 | $380 |
| Bayer | 19 | $364 |
| Novo Nordisk | 21 | $354 |
| Abbott | 16 | $341 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $260 |
| AbbVie | 12 | $192 |
| GSK | 9 | $165 |
| Supernus Pharmaceuticals, Inc. | 7 | $141 |
| Johnson & Johnson | 9 | $135 |
| Pfizer | 6 | $118 |
| Merck | 8 | $118 |
| Kowa Pharmaceuticals America, Inc. | 6 | $109 |
| Boehringer Ingelheim | 5 | $91 |
| Amgen | 5 | $76 |
| Xeris Pharmaceuticals, Inc. | 4 | $66 |
| AstraZeneca | 3 | $57 |
| Sanofi Pasteur Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $25 |
| Organon | 1 | $24 |
| Adlon Therapeutics L.p. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
How this compares
$3,109 in reported general payments places this provider in the 85th percentile of 1,246 physician assistant providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 27 | $26,497 |
| TrulicityDulaglutide | 19 | $20,285 |
| VraylarCariprazine Hcl | 12 | $17,058 |
| OzempicSemaglutide | 11 | $12,538 |
| EliquisApixaban | 17 | $12,534 |
| JanuviaSitagliptin Phosphate | 13 | $11,225 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $2,014 |
| Pregabalin | 13 | $1,101 |
| Divalproex Sodium | 17 | $857 |
| Rosuvastatin Calcium | 66 | $852 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $817 |
| FenofibrateFenofibrate Nanocrystallized | 18 | $690 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 16 | $662 |
| Pantoprazole Sodium | 64 | $548 |
| Atorvastatin Calcium | 56 | $492 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $91 | $26,49727 claims |
| Lilly USA, LLCTrulicity | $380 | $20,28519 claims |
| AbbVieVraylar | $192 | $17,05812 claims |
| Novo NordiskOzempic | $354 | $12,53811 claims |
| PfizerEliquis | $118 | $12,53417 claims |
| MerckJanuvia | $118 | $11,22513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,246 physician assistant providers in Louisiana.
Other physician assistant in Baker
- Shelly EsnardBaton Rouge$141K
- Jefferson OberleNew Orleans$66K
- Jennifer ScheuermannNew Orleans$56K
- Claire DarreJefferson$50K
- Elizabeth ClementNew Orleans$35K
- Mary Negrotto GuntherSlidell$29K
- Kristen HebertZachary$27K
- David GsellNew Orleans$26K
- Nakia BrooksNew Orleans$25K
- Savannah SanchezBaton Rouge$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.